Incidence of adverse drug reaction and its outcome among patients in tertiary care hospital, Uttar Pradesh
Keywords:
adverse drug reactions, incidence, outcome, patientsAbstract
Introduction: World Health Organization defines adverse drug reactions (ADRs) as any noxious, unintended, and undesired effect of a drug, which occurs at doses used in humans for prophylaxis, diagnosis, or therapy. For evaluating the incidence and outcome of adverse drug reactions (ADRs) to assist in minimizing the deleterious effects, the present study was planned to find the incidence of ADR, its severity, and outcomes among patients. Material and Methods: The spontaneous ADR reporting technique and the Suspected Adverse Drug Reaction Reporting Form were used for the data collection and reporting. All patients who developed an ADR during the study period has included. By using Expanded Rawlins and Thompson’s classification, all patients were categorized into types A to F and classified according to the severity levels (mild, moderate, severe) by applying the Modified Hartwig severity scale. The classification of outcomes of the ADRs was done as per WHO criteria as fatal, continuing, recovering, recovered, unknown, or any other. Results: Type B (Bizarre) ADRs were found to be the most frequently occurring ADRs (51%) followed by type A (Augmented) 29%. Maximum ADR cases were found in the 12-45 years age group (58%).
Downloads
References
Alvarez-Requejo A, Carvajal A, Begaud B, et al. Under-reporting of adverse drug reactions, Estimate based on a spontaneous reporting scheme and a sentinel system, European Journal of Clinical Pharmacology. 1998; 54(6): 483-8.
Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. British journal of clinical pharmacology. 2008; 65(2): 210-216.
Bista, D, et al. Pattern of adverse drug reactions reported to the regional Pharmacovigilance center at Nepal Medical College and Teaching Hospital, Kathmandu. Journal of Nepal Pharmaceutical Association. 2012; 26(1): 54-61.
Davies DM. 2000 years of adverse drug reactions. Adverse Drug Reaction Bulletin. 1999; 199: 759-62.
Eland IA, Belton KJ, Van AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Britain Journal of Clinical Pharmacology. 1999; 48(4): 623-7.
Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a viewpoint. British journal of clinical pharmacology. 2008; 65(5): 795-796.
Jose J, Padma GMR. The pattern of adverse drug reactions notified by spontaneous reporting in Indian tertiary care teaching hospital. Pharmacological research. 2006; 54(3): 226-233.
Kaufman, David W, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. The Journal of the American Medical Association. 2002; 287(3): 337-344.
Kaur S, Kapoor V, Mahajan R, Lal M, Gupta S. Patterns of ADRs and Risk Factors Involved: Study in Cardiology Unit of An Indian Tertiary Care Center. The Internet Journal of Pharmacology. 2010; 1: 8.
Kavitha D. Adverse Drug Reaction (ADRs) Monitoring And Pharmacovigilance. Journal of Pharmaceutical Research and Health Care. 2010; 2 (1): 127-134.
Lobo, et al. Adverse drug reaction monitoring: support for Pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacology and Toxicology. 2013; 14: 5.
Madhan R, Gurumurthy P. Adverse drug reaction reporting: Attitudes and perceptions of medical practitioners. Asian Journal of Pharmaceutical and Clinical Research. 2009; 2(2): 10-4.
Martin RM, et al. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. British journal of clinical pharmacology. 1998; 46(5): 505-511.
Padmaja U, Adhikari P, Pereira P. A Prospective Analysis of Adverse Drug Reactions in a South Indian Hospital, Online Journal of Health Allied Sciences. 2009; 8: 3.
Qato, Dima M, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. The Journal of the American Medical Association. 2008; 300(24): 2867-2878.
Ramesh M., Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital-their severity and cost involved. Pharmacoepidemiology and drug safety. 2003; 12(8): 687-692.
Shanthi NP, Chris D, Dennis F, Sten O. Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems. WHO. Drug Safety 2013; 36: 75-81.
Varma SK, Nagpure S, Misra AK, et al. Fixed drug eruption due to fixed dose combination: A novel case. International Journal of Health & Allied Sciences. 2013; 2(2): 130.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
